Point Of Care Connectivity Solutions Market Size, Share & Trends Analysis Report By Type (Software, Services), By Application, By End Use (Hospitals, Diagnostic Centers, Specialty Centers, Outpatient Facilities), By Region, And Segment Forecasts, 2024 - 2
Point Of Care Connectivity Solutions Market Size, Share & Trends Analysis Report By Type (Software, Services), By Application, By End Use (Hospitals, Diagnostic Centers, Specialty Centers, Outpatient Facilities), By Region, And Segment Forecasts, 2024 - 2030
Point of Care Connectivity Solutions Market Growth & Trends
The global point of care connectivity solutions market size is anticipated to reach USD 1.68 billion by 2030 and is projected to grow at a CAGR of 7.40% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth is primarily driven by the increasing need for real-time access to patient data and enhanced diagnostic accuracy. Advances in digital health technologies, such as cloud computing and electronic health records (EHRs), facilitate seamless data integration and improved decision-making. In addition, regulatory requirements for better healthcare outcomes and cost reduction, along with the demand for digital transformation in healthcare settings, contribute significantly to the market's expansion.
Increasing adoption of electronic health records (EHRs) is driving POC connectivity solutions by enhancing the integration and accessibility of patient data at the point of care. EHRs facilitate the seamless exchange of information between healthcare providers, enabling real-time updates and comprehensive patient records. This integration supports more accurate and timely diagnostics, streamlines workflows, and improves overall patient care. As healthcare systems adopt EHRs more widely, the demand for POC connectivity solutions grows to ensure effective data management and connectivity across various healthcare settings. Moreover, POC connectivity enables automated billing for all POC tests, addressing revenue leakage issues. Tests not recorded in the EHR can lead to revenue losses of up to 20%, making accurate data capture and integration crucial for minimizing financial losses and optimizing revenue management.
Market players are undertaking several strategic initiatives to increase the adoption of POC connectivity solutions. For instance, in June 2022, OptimizeRx Corp. completed the integration of TelaRep's one-click prescriber connectivity solution into its Therapy Initiation and Persistence Platform. This integration enables physicians to connect with pharmaceutical representatives directly from the EHR system.
Cloud technology drives the POC connectivity solutions by enabling real-time data access and integration across various healthcare systems. It supports the seamless exchange of patient information, facilitating more accurate and timely diagnostics. Cloud solutions enhance scalability, allowing healthcare providers to efficiently manage and store large volumes of data without the constraints of on-premises infrastructure. In addition, they enable remote access to critical health information, improving collaboration among healthcare teams and ultimately leading to better patient outcomes.
Moreover, the mention of government initiatives, such as Oracle's August 2024 cloud expansion in Saudi Arabia, illustrates how strategic investments align with national goals like Saudi Vision 2030. Oracle’s USD 1.5 billion investment in expanding cloud infrastructure, particularly in Riyadh, supports the growing demand for AI and cloud services. This enables both public and private sector organizations to leverage Oracle Cloud Infrastructure (OCI) to modernize workloads, including data analytics and artificial intelligence applications.
Point of Care Connectivity Solutions Market Report Highlights
Based on type mode, the software segment led the market with the largest revenue share of 72.97% in 2023. The growth is attributed to its role in integrating multiple devices, enabling seamless data exchange with healthcare systems like EMRs, LISs, and other platforms
Based on application mode, the hematology segment led the market with the largest revenue share of 16.78% in 2023. The market growth is due to the high demand for real-time blood analysis to diagnose and manage conditions like anemia and leukemia
Based on end use, the hospitals segment led the market with the largest revenue share of 29.88% in 2023. The hospital segment dominated the market due to hospitals' need for seamless integration of POC devices with centralized systems like EMRs, LISs, and HISs
North America dominated the market with the largest revenue share of 30.63% in 2023. The market growth is driven by advancements in healthcare technology and the increasing adoption of electronic health records (EHRs)
Please note The report will be delivered in 2-3 business days upon order notification.
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Point of Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Point of Care (POC) Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.3.3. COVID-19 Impact
3.3.4. Case Study
Chapter 4. Point of Care Market: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Point of Care (POC) Market by Type Outlook
4.4. Software
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Services
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Point of Care Market: Application Estimates & Trend Analysis
5.1. Application Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Point of Care (POC) Market by Application Outlook
5.4. Glucose Monitoring
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Coagulation Monitoring
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Electrolyte and Blood Gas Analysis
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.7. Infectious Disease Devices
5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.8. Cardio metabolic Monitoring
5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.9. Hematology
5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.10. Others (Cancer Markers, Drug Abuse Testing, etc)
5.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Point of Care Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Point of Care (POC) Market by End Use Outlook
6.4. Hospitals
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. Diagnostic Centers
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Specialty Centers
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.7. Outpatients Facilities (including Ambulatory Care Centers, etc.)
6.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.8. Others
6.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Point of Care Market: Regional Estimates & Trend Analysis, By Type, By Application, By End Use
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Innovators
8.4. Vendor Landscape
8.4.1. List of key distributors and channel partners
8.4.2. Key customers
8.4.3. Key company market share analysis, 2023
8.4.4. F. Hoffmann-La Roche Ltd.
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Technology Type benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Siemens Healthineers
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Technology Type benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Abbott
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Technology Type benchmarking
8.4.6.4. Strategic initiatives
8.4.7. GE Healthcare
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Technology Type benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Masimo
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Technology Type benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Capsule Technologies, Inc. (Koninklijke Philips N.V.)